☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Foundation Medicine
Foundation Medicine Receives the US FDA’s Approval of FoundationOne CDx for Eli Lilly's Retevmo to Treat Solid Tumors
October 10, 2023
PharmaShots Weekly Snapshot (Jun 15-19, 2020)
June 22, 2020
Foundation Medicine Acquires Lexent to Expand its Liquid Biopsy Platforms
June 15, 2020
Foundation Medicine's FoundationOne CDx Receives FDA's Approval as a CDx for Lynparza (olaparib)
July 2, 2019
Bayer Signs a Worldwide Agreement with Roche's Foundation Medicine to Develop and Commercialize CDx for Cancer
May 29, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.